Brief: Exact Therapeutics Gets Investment From GE Healthcare
Dec 2 (Reuters) - Exact Therapeutics AS EXTX.OL :
* GETS INVESTMENT FROM GE HEALTHCARE TO ADVANCE THERAPEUTIC
ULTRASOUND IN PANCREATIC CANCER USING ACT®
* GE HEALTHCARE TO PARTICIPATE AS CORNERSTONE INVESTOR,
INVEST 7
MUSD IN PRIVATE PLACEMENT IN EXACT THERAPEUTICS
* ANTICIPATED THAT PRIVATE PLACEMENT WILL FUND EXACT
THERAPEUTICS'
PHASE 2 ENACT STUDY IN PANCREATIC CANCER
Source text: ID:nObimpTpPa
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial